DrugScope Latest

DrugScope annual conference 2009

London, Wednesday 28th October

 

Recovery and Drug Dependency: A new deal for families

PDF)

 

DrugScope/ICM poll into attitudes to drug treatment

 

NTA naloxone pilot scheme can help reduce drug-related deaths

DrugScope press release

 

Home Affairs Select Committee, Cocaine Inquiry - oral evidence

(DrugScope witnesses at 32 mins)

 
Good Practice case studies:

Studies of local projects (PDF)

 
Drug treatment EDM:

DrugScope is calling on people to ask their local MP to support a parliamentary motion recognising the benefits of drug treatment.

 

DrugScope evidence to the Royal College of Psychiatrists:

DrugScope gave oral evidence to an inquiry on suicide and self-harm and made a written submission to the Royal College of Psychiatrists.

 

DrugScope updates

More from Drugscope

If you'd like to sign up for updates about DrugScope's work please click here


Welcome to
DS Daily

 

Welcome to DS Daily, our new daily drug and alcohol news service. We are launching the service both as part of our core commitment to the provision and dissemination of up to date information and in support of our role as a membership organisation for the sector. The service will operate every weekday, plus you can subscribe to a weekly email which will provide you with a summary of the week's news.

 

We are also very pleased to announce that Jim Young, formerly of Daily Dose, has joined our DS Daily team.

 

We are very keen to receive your comments about the new service which you can send to the Editor, Jim Young at jimy@drugscope.org.uk

 

 

 

Bookmark and Share

 



 


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Terms of use

 

Disclaimer

This website is intended purely as an information resource. DrugScope does not guarantee the accuracy of the information provided by external sources/links, and accepts no responsibility or liability for any consequences arising from the use of such data. Furthermore, we cannot be held responsible for the privacy of data collected by websites not managed by DrugScope.

 

Terms and conditions

Access to and use of this site is provided by DrugScope subject to the following terms:

 

By using this site you agree to be legally bound by these terms, which shall take effect immediately on your first use of the site. If you do not agree to be legally bound by all the following terms please do not access and/or use the DrugScope website.

 

DrugScope may change these terms at any time by posting changes online. Please review these terms regularly to ensure you are aware of any changes. Your continued use of the DrugScope site after changes are posted means you agree to be legally bound by these terms as updated and/or amended.

 

Use of the DS Daily website

 

This site is the property of DrugScope and is protected by copyright. You may not copy, reproduce, republish, download, post, broadcast or otherwise use DS Daily conent in any way except for your own personal, non-commercial use. You also agree not to adapt, alter or create a derivative work from any DS Daily content except for your own personal, non-commercial use.

 

Those wishing to use the contents of this site for purposes other than their personal use are requested to apply in writing to the Webmaster, DrugScope, Prince Consort House, Suite 204 (2nd Floor), 109/111 Farringdon Road, London EC1R 3BW.

 

Links to this web site should not be made without the prior permission of DrugScope. Please contact Jackie Buckle, Webmaster, DrugScope, Prince Consort House, Suite 204 (2nd Floor), 109/111 Farringdon Road, London EC1R 3BW, or email: webmaster@drugscope.org.uk

 

In using the DS Daily site you agree to use it only for lawful purposes, and in a way that does not infringe the rights of, restrict or inhibit anyone else's use of the site.